President Trump Secures New Deal to Lower Drug Prices for Americans
TL;DR
President Trump announced a deal with AstraZeneca to align U.S. drug prices with those of other developed nations, resulting in significant savings for American patients and Medicaid programs, while also investing $50 billion in U.S. pharmaceutical manufacturing and R&D. The agreement includes discounts on key medicines for asthma and COPD, and aims to end the practice of foreign countries subsidizing their healthcare through higher U.S. drug prices.
Topics:nationhealthcare#astrazeneca#drug-pricing#healthcare#mfn-pricing#pharmaceutical-investment#president-trump
- Fact Sheet: President Donald J. Trump Announces Second Deal to Bring Most-Favored-Nation Pricing to American Patients The White House (.gov)
- AstraZeneca makes deal with White House to lower drug prices NPR
- Trump says AstraZeneca to offer drugs to US at discounted prices Reuters
- Donald Trump’s Big Pharma Showdown Ends with a Whimper The New Yorker
- TrumpRX Is a Prescription for Lower Drug Prices | Opinion Newsweek
Want the full story? Read the original reporting
Read on The White House (.gov)